stella
beta
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5 — Stella
Home
/
Chronic Kidney Disease (Stages 3b-5)
/
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
View on ClinicalTrials.gov
Recruiting
Back to Chronic Kidney Disease (Stages 3b-5) trials
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(3 sites)
China
Peking University First Hospital, Beijing, Beijing Municipality
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi
Hubei Provincial Hospital of TCM, Wuhan, Hubei